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Increased Drp1 promotes autophagy
and ESCC progression by mtDNA stress
mediated cGAS‑STING pathway
Yujia Li1,2†, Hui Chen1†, Qi Yang1,2†, Lixin Wan3, Jing Zhao1, Yuanyuan Wu1, Jiaxin Wang1, Yating Yang1,
Menglan Niu1, Hongliang Liu1, Junqi Liu4, Hushan Yang5, Shaogui Wan1,6*, Yanming Wang2* and Dengke Bao1,3*

Abstract
Background: Mitochondrial dynamics homeostasis is important for cell metabolism, growth, proliferation, and
immune responses. The critical GTPase for mitochondrial fission, Drp1 is frequently upregulated in many cancers and
is closely implicated in tumorigenesis. However, the mechanism underling Drp1 to influence tumor progression is
largely unknown, especially in esophageal squamous cell carcinoma (ESCC).
Methods: Immunohistochemistry was used to examine Drp1 and LC3B expression in tissues of ESCC patients.
Autophagic vesicles were investigated by transmission electron microscopy. Fluorescent LC3B puncta and mitochondrial nucleoid were observed by fluorescent and confocal microscopy. Mitochondrial function was evaluated by
mitochondrial membrane potential, ROS and ATP levels. Xenograft tumor model was performed in BALB/c nude mice
to analyze the role of Drp1 on ESCC progression.
Results: We found that Drp1 high expression is correlated with poor overall survival of ESCC patients. Drp1 overexpression promotes cell proliferation and xenograft ESCC tumor growth by triggering autophagy. Furthermore, we
demonstrated that Drp1 overexpression disturbs mitochondrial function and subsequent induces mitochondrial
DNA (mtDNA) released into the cytosol thereby inducing cytosolic mtDNA stress. Mechanistically, cytosolic mtDNA
activates the cGAS-STING pathway and facilitates autophagy, which promotes ESCC cancer growth. Moreover, mtDNA
digestion with DNase I and autophagy inhibition with chloroquine attenuates the cGAS-STING pathway activation
and ESCC cancer growth.
Conclusions: Our finding reveals that Drp1 overexpression induces mitochondrial dysfunction and cytosolic mtDNA
stress, which subsequently activates the cGAS-STING pathway, triggers autophagy and promotes ESCC progression.
Keywords: Mitochondrial DNA stress, Autophagy, cGAS-STING signaling pathway, Drp1, Esophageal Squamous Cell
Carcinoma
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Background
Mitochondria are vital intracellular organelles involved in
cellular metabolism, ATP generation and more recently,
innate immunity [1, 2]. Accumulating evidence suggests that mitochondrial mass and dynamics play a
central and multi-functional role in tumor progression
by modulating cell cycle, redox homeostasis, metabolism and immune signals [3, 4]. Previous studies have
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demonstrated that the critical GTPase for mitochondrial
dynamics, Drp1 is frequently upregulated in lung cancer
and hepatocellular carcinoma (HCC), which is closely
implicated in tumorigenesis [5, 6]. However, the underling mechanism by Drp1 influence tumor progression is
largely unknown, especially in esophageal squamous cell
carcinoma (ESCC).
Recently, damage-associated molecular patterns
(DAMPs) from mitochondria were implicated in various
chronic inflammatory diseases such as trauma, autoimmune disorders, ischemic heart disease and cancer [7, 8].
As a major mitochondrial DAMPs, mitochondrial DNA
(mtDNA) plays an important role in tumor progression
and metastasis [9, 10]. Using heterozygote TFAM (mitochondrial transcription factor A) knockout mice, it was
demonstrated that TFAM deficiency causes markedly
induces mtDNA instability and cytoplasm release, which
is recognized as cytosolic mtDNA stress [2]. Further
studies showed that during hypoxia, nuclear HMGB1
translocate to the cytoplasm and binds to mtDNA, which
then activates TLR9 signaling and tumor proliferation
in hepatocellular carcinoma (HCC) [11]. We previously
found that increased mitochondrial fission through
upregulated Drp1 significantly induced cytosolic mtDNA
stress and subsequent CCL2 secretion in HCC cells,
leading to infiltration of tumor-associated macrophages
into HCC tissues and tumor progression [12]. However,
whether mtDNA stress is involved in esophageal squamous cell carcinoma (ESCC) progression remains poorly
understood.
cGAS (cyclic GMP-AMP synthase) is a cytosolic DNA
sensor, which activates STING (stimulator of interferon
genes) through the second messenger molecule cGAMP
(2′3’-cGMP-AMP) to induce innate immunity [13, 14].
Recent studies found the cGAS-STING signaling cascade is involved in anticancer immune responses and
cancer immune escape, which plays dichotomous effects
on tumor development [15–18]. The cGAS-STING pathway activation by tumor-derived DNA can induce cellular senescence, pro-inflammatory cytokine expression,
and immuno-surveillance to suppress tumorigenesis by
promoting the release of type I interferons (IFNs) [15,
16]. Further, the STING activation by cytosolic DNA is
involved in mediating innate immune recognition of
immunogenic tumors [19]. However, prolonged type I
IFNs signaling induced by the cGAS-STING pathway can
cause immune dysfunction and promote tumor development [17, 20]. Moreover, STING signaling also facilitates
tumor growth, chemoresistance and metastasis in breast
cancer and lung cancer mainly by creating an immune
suppressive tumor microenvironment [21–25]. Cytosolic
mtDNA, which leaks under mitochondrial stress, can
also trigger the cGAS-STING pathway and induce the
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production of inflammatory cytokines and type I IFNs
[2, 26, 27]. However, it is unclear if mtDNA stress activates the cGAS-STING pathway in the context of ESCC
progression.
Autophagy is evolutionarily conserved cellular process
wherein cellular components such as macromolecules
and organelles degrade through sequentially formed
autophagic vesicles including phagophores, autophagosomes and autolysosomes [28]. The formation of
autophagic vesicles and the recruitment of cellular components into autophagic vesicles are tightly regulated by
a series of autophagy factors, including LC3B and p62. It
had been reported that autophagy is also a cellular process adapted by cancer cells to cope with various adverse
conditions, such as oxidative stress, ER stress, mitochondria stress and starvation [29]. Autophagy plays a tumor
suppression or promotion role depending on cellular
context and tumor microenvironment, and autophagy
inhibitors have been tested in combination with other
chemotherapy reagents in clinical trials [30–32].
In this study, we examined the role of Drp1 on ESCC
progression in vitro and in vivo. Furthermore, we investigated whether the cGAS-STING pathway mediated
autophagy is implicated in Drp1-induced ESCC progression. Our findings provide novel insight into the molecular mechanisms underlying mitochondrial dynamics and
ESCC progression.

Methods and materials
Animals

Four-week-old female BALB/c nude mice were randomly
divided into indicated groups, at least 7 each group. Xenograft nude mice model was established by subcutaneously injecting ESCC cells (5 × 106 cells per mice) into the
right flanks. Tumor size was measured weekly, and volume was calculated according to the following formula:
volume = ( Width2 × Length)/2. After injection 6 weeks,
all mice were sacrificed and the tumors were harvested
and weighted. The tumor tissue samples were evaluated
by H&E staining and immunohistochemistry. Animal
study was approved by the Institutional Animal Care and
Use Committee of Henan University.
Human tissue samples

A total of 61 paired ESCC tissue specimens from both
tumor and adjacent normal tissues were obtained from
untreated patients who underwent surgical treatment
for ESCC at the Nanyang central Hospital of Henan University. The latest follow-up date was August 2017 and
the clinical characteristics of all patients was distributed in Table S1. All samples were cut into two pieces.
One piece was embedded in paraffin and processed for
routine histopathological examination, while the other
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piece of tissue was frozen immediately in liquid nitrogen
and stored at -80℃ for further studies. All patients were
clinically and pathologically diagnosed to have ESCC.
This study was approved by Ethics Committee of Henan
University, and the informed consents were signed by all
participants.
Cell culture

Human ESCC cell lines KYSE-30, KYSE-70, KYSE-140,
EC9706, KYSE-30 and EC9706 with Drp1 overexpression, KYSE-70 and KYSE-140 with Drp1 knockdown,
and normal esophageal epithelial cell line Het-1A were
routinely cultured in RPMI-1640 (10,040-CVR, Corning) medium supplemented with 10% fetal bovine serum
(04–001-1Acs, BI). All cell lines were verified based on
cell morphology and authenticated using short tandem
repeat (STR) DNA testing.
Knockdown and forced expression of target genes

For transfection, KYSE-30, KYSE-140, EC9706 and
KYSE-70 cells were seeded in 6-well plates to 60% to
80% confluence. Then the vectors with or without target
gene were respectively transfected into ESCC cells using
the Lipofectamine 2000 reagent (11,668,019, Invitrogen) according to the manufacturer’s instructions. Stable
transfectants were generated by limiting dilution after
selection with G418 (10,131,027, Invitrogen) for 3 weeks.
The recombinant DNA used in this study are listed in
Table S2. All siRNAs were synthesized by GenePharma
(Shanghai, China). The siRNA sequences of Drp1, TFAM,
TBK1, STING, and cGAS are provided in Table S2.
The siRNAs were transfected with Lipofectamine 2000
(11,668,019, Invitrogen) reagent according to the manufacturer’s protocol.
Determination of mtDNA copies in cytosolic extracts

Cytosol fraction of ESCC cells were isolated using the
cell mitochondria isolation kit (C3601, Beyotime) following the manufacturer’s instructions as previously
described [12]. In brief, 1 × 107 cells were incubated in
0.1 ml ice-cold mitochondrial lyses buffer for 10 min
and homogenized with a Dounce homogenizer for 30
strokes. The homogenate was centrifuged at 600 × g
for 10 min at 4 °C to remove nuclei and unbroken cells.
The supernatant was collected and centrifuged again
at 12,000 × g for 30 min at 4 °C for production of a
supernatant corresponding to the cytosolic fraction.
DNA of cytosolic fractions were isolated using TIANamp Genomic DNA Kit (DP304, TIANGEN) according
to the manufacturer’s protocol. Cytosolic mtDNA was
measured using the QX200™ Droplet Digital™ PCR System (QX200™, Bio-Rad Laboratories). Briefly, the 20 μl
ddPCR reaction consisted of 2 × ddPCR Super Mix for
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probe 10 μl, 900 nM ND1-Forward and ND1-Reverse
primers, 500 nM probe for ND1. The ddPCR reaction
mixture and 70 μl of droplet generation oil for probe
were placed into the DG8 cartridge (QX200™, BioRad Laboratories) after equilibrating for 3 min at room
temperature. After generating by droplet generator
(QX200™, Bio-Rad Laboratories), the droplet emulsion
was transferred to 96-well PCR plate (QX200™, Bio-Rad
Laboratories) and subsequently heat-sealed using PX1™
PCR plate sealer (QX200™, Bio-Rad Laboratories) and
PCR reaction was performed with a condition as follows: 95℃ for 10 min; 40 cycles of 95℃ for 30 s, 55℃
for 1 min; and a final step at 72℃ for 10 min. The absolute mtDNA concentration was analyzed by the QX200
droplet reader software, version 1.6.6.0320 (QX200™,
Bio-Rad Laboratories) after PCR amplification.
qRT‑PCR, Western blot, IHC, and H&E staining.

Total RNA extraction, complementary DNA synthesis,
and qRT-PCR were performed as previously described
[12]. Primer sequences of qRT-PCR were provided in
Table S2. ESCC tissues and cell lines were processed
for western blot and IHC as previously described [12].
The band intensity on the western blots was quantified using Quantity One software (Hercules, Bio-Rad).
Antibodies were shown in Table S3. The fold change
between tumor and adjacent nontumor tissues were
log2-transformed for further analysis.
Autophagic vesicles imaging by transmission electron
microscopy and mitochondrial nucleoid imaging
by confocal microscopy

Cells were fixed with 4% glutaraldehyde and post fixed
with 1% 
OsO4 in 0.1 M cacodylate buffer containing 0.1% C
 aCl2 for 2 h at 4 °C. The samples were then
stained with 1% uranyl acetate, dehydrated in increasing concentrations of ethanol and embedded in araldite.
Thin sections were stained with uranylacetate and lead
citrate and analyzed with an electron microscope (Tecnai G2, FEI), at 11,500 magnifications.
ESCC cells were first with washed with HBSS and
incubated with MitoTracker Red FM (M7512, Invivogen) for 0.5 h, and then incubated with Picogreen
(P2023, UE) after another washing with HBSS for
1.5 h. Then, the distribution of mitochondrial nucleoids in living ESCC cells mitochondrial morphology
was immediately monitored using Nikon N-SIM Structured Illumination microscope (Nikon/A1 + N-SIM,
Nikon). For morphometric analysis, Image J software
(NIH, Bethesda, MD) was used to measure the length
of mitochondria.
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Cell viability and proliferation assays

monomers to JC-1 aggregates (ratio of 529:590 nm emission intensity).
The total ATP were measured by plating 1 × 105 cells in
6-well plates overnight, and then the cells were counted
for ATP. The total ATP levels were determined using
the Cell Titer-Glo Luminescent assay (G7570, Promega)
according to the manufacture. The data were normalized
to the number of cells.

Cell viability was determined by the MTS assay (G3580,
Promega Corporation) according to the manufacturer’s instructions. Briefly, 2000 cells/well were plated
in each well of a 96-well culture plate. After 1, 2, 3, 4,
5 days, cell viability was measured by addition of 20 μl
of MTS solution and incubation for another 3 h. The
absorbance of optical density (OD) was determined by
PerkinElmer EnSpire microplate reader with a 490 nm
wavelength. Each group were performed in triplicate.
Cell’s proliferation was determined by colony formation
assay and ethynyl deoxyuridine (EdU) incorporation
assay (C10310-1, Ribbio). ESCC cells were inculcated
into 6-well plate with 1000 cells/well and cultured for
two weeks at 5% C
 O2, 37℃. Then, cells were fixed with
4% paraformaldehyde for 15 min, washed three times
with PBS and incubated with 0.5% crystal violet solution for another 5 min. The colonies were counted
and assays from three independent experiments. EdU
incorporation assay was used to evaluate the proliferation of cells according to the manufacturer’s instructions (C10310-1, Ribbio). Then results were analyzed
with a fluorescence microscope (U-LH100HG, Olympus Corporation).
RNA sequencing

Total RNA of ESCC cells as indicated were extraction
as previously described [12]. The integrity of RNA from
ESCC cells were examined with Bioanalyzer 2100 (Agilent, Santa Clara, CA), and RNA samples with RIN > 7
were subjected to library construction and sequenced on
Illumina novaseq by Genewiz Suzhou, In. Differentially
expressed of mRNAs were analyzed as previous reported
[33].
Detection of reactive oxygen species, mitochondrial
membrane potential and ATP measurement

Cellular reactive oxygen species (ROS) levels were
detected by the fluorescent probe DCFH-DA (S0033S,
Beyotime Biotechnology) following the manufacturer’s
protocols. Briefly, ESCC cells suspension was incubated with 10 μM DCFH-DA, which diluted with serum
free medium, at 37 °C for 20 min. The fluorescence was
assessed by flow cytometry.
JC-1 dye (C2006, Beyotime Biotechnology) was used
to detect the mitochondrial membrane potential. Cells
were adjusted to a density of 1 × 105/ml and stained with
5 mg/L JC-1 dye for 20 min at 37℃. After washing with
the dye buffer three time, the cells were observed to a
fluorescence microscope (U-LH100HG, Olympus Corporation) and detected fluorescence intensity ratio of JC-1

DNase I was delivered into cytosol using PULSin™ protein delivery reagent (501–01, Polyplus Transfection) following the manufacturer’s protocols. Firstly, 3 μg DNaseI
was mixed with PULSin according to the manufacturer’s
instructions. After washing three times using serum-free
RPMI-1640, the cells were incubated with DNase I/PULSin mixture for 4 h at 37℃. Then, removing the mixture
and incubating in fresh complete medium for another
24 h. Finally, the cells were collected for further studies.
DNase I treatment

Evaluation of fluorescent LC3B puncta

ESCC cells were first transiently transfected with
pcDNA3.1-GFP-LC3B (B5500, GenePharma) and then
stained with Hoechst 33,342 (H4047, UE). The LC3B
fluorescent puncta were viewed using Nikon N-SIM
Structured Illumination microscope (Nikon/A1 + N-SIM,
Nikon). The average number of GFP-LC3B puncta per
cell in 5 high-power fields (HPF, 400 ×) was calculated,
which was identified as autophagy.
Statistics and reproducibility

Unpaired Student’s t-tests (two-sided) were used for
comparisons between two groups where appropriate.
Error bars represent standard error of mean. For prognosis analysis, variables (the IHC score of Drp1, LC3B) were
analyzed dichotomically. The Kaplan–Meier survival
curve and log-rank test were used to distinguish subgroup patients who had different overall survival. People
who performed lab work were blinded to patients’ clinical data and no blinding was done for all animal studies.
For every figure, the statistical tests are justified as appropriate and the data meet the assumptions of the tests.
All experiments were technically repeated at least three
times. SPSS 20.0 software (IBM, Chicago, IL) was used
for all statistical analyses and p < 0.05 was considered statistically significant.

Results
Drp1‑mediated mitochondrial fission promoted survival
of ESCC cells in vitro and in vivo

To investigate whether mitochondrial regulators Drp1 is
involved in ESCC progression, we analyzed Drp1 expression in a cohort of 61 ESCC patients. Through IHC
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staining, we found that Drp1 expression was significantly
upregulated in ESCC tumors in comparison to peritumor tissues (Fig. 1A). We further performed protein and
mRNA analyses and found that tumors tend to express
higher amounts of Drp1 than peritumor tissues (Fig. 1B
and C). Moreover, patients with higher Drp1 expression
had significantly shorter overall survival (Fig. 1D), suggesting that Drp1 plays pivotal roles in ESCC progression.
The above results prompted us to investigate the
molecular functions of Drp1 in ESCC progression.
We first investigated the expression of Drp1 in several
ESCC cell lines and normal esophageal epithelial cell
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line Het-1A. We found that Drp1 expression was much
higher in ESCC cells compared with Het-1A (Fig. S1AB). In ESCC cell lines, the Drp1 expression was much
higher in KYSE-140 and KYSE-70 cells compared with
EC9706 and KYSE-30 cells (Fig. S1A-B). Next, we performed Drp1 overexpression with a vector in KYSE-30
and EC9706 ESCC cells which have relatively low Drp1
expression levels (Fig. S1A-F). We found that Drp1 overexpression increased the percentage of cells with fragmented mitochondria, with a decreased percentage of
cells with elongated mitochondria (Fig. S1G-H). Next,
we analyzed the potential roles of Drp1 on the growth

Fig. 1 Drp1-mediated mitochondrial fission promoted survival of ESCC cells in vitro and in vivo. (A) Representative immunohistochemical
(IHC) staining images of Drp1 and TFAM in paired ESCC tissues (n = 61). Scale bar: 100 μm. (B and C) Western blot and qRT-PCR analyses for the
expression levels of Drp1 TFAM in paired tissues from ESCC patients. T, tumor; P, peritumor. The relative expression ratio of tumor to peritumor was
log2-transformed for further analysis. (D)Kaplan–Meier curve analysis of overall survival in ESCC patients grouped by the expression of Drp1 in
tumor tissues. Patients were grouped into high or low level using the median value of IHC scores. Death/total number of patients in each subgroup
were presented. (E)Colony-forming potential were detected in ESCC cells with treatment as indicated. Scale bar: 10 mm. The data shown are
the mean ± SEM from three separate experiments. (F) Cell proliferation was evaluated by EdU incorporation assay in KYSE-30 cells as indicated.
Scale bar: 200 μm. (G) Cell viability of KYSE-30 ESCC cells with Drp1 overexpression were evaluated using the MTS cell proliferation assay. (H and
I) Tumor growth curves and weight of subcutaneous xenograft tumor model developed from ESCC cells with Drp1 overexpression (n = 6). The
tumor volumes were calculated according to the formula (L × W2)/2 and presented as mean ± SEM. (J) Representative immunohistochemical (IHC)
staining images of Ki67 in xenograft tumors developed from KYSE-30 cells with Drp1 overexpression. Scale bar: 100 μm. The data shown are the
mean ± SEM from three separate experiments. Drp1, expression vector encoding Drp1; EV, empty vector. P value from t tests. *, P < 0.05; **, P < 0.01;
***, P < 0.001
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of ESCC. Elevation of Drp1 expression in the KYSE-30
and EC9706 ESCC cell line significantly increased colony formation, EdU incorporation, and cell growth rate
(Fig. 1E-G, and Fig. S2). The results were confirmed by a
subcutaneous xenograft model in nude mice. The growth
curve and tumor weight analyses found that in KYSE-30
cells derived xenograft tumor, elevation of Drp1 expression significantly increased tumor growth rate and tumor
weight (Fig. 1H and I), and increased the percentage of
Ki67+ cells in the xenograft tumors (Fig. 1J). These results
indicate that Drp1 accelerates xenograft tumor growth of
ESCC.
Drp1 inhibitor or knockdown exhibits an anticancer effect
on ESCC in vitro and in vivo

To explore the potential roles of Drp1 on ESCC cells
survival, Drp1 expression was knockdown by shRNA or
blockage by Drp1 selective inhibitor Mdivi-1 in KYSE70 and KYSE-140 cells which have relatively high Drp1
expression levels (Fig. S1A-B, S3A-B, and S4A-B). The
percentage of cells with fragmented mitochondria significantly reduced and the percentage of cells with elongated mitochondria significantly increased with Drp1
knockdown or Mdivi-1 treatment (Fig. S3C-D, and S4CD). Consistently, Drp1 knockdown or Mdivi-1 treatment
were also can inhibit ESCC cells survival in vitro and
in vivo, which were investigated by EdU incorporation
assay, MTS assay and colony formation assay and xenograft nude mice model (Fig. 2, and Fig S5). These data
further support that Drp1 maybe a critical factor for
ESCC progression.
Drp1 overexpression regulates autophagy in ESCC cells

To investigate the underlying mechanisms of Drp1 overexpression-mediated ESCC progression, transcriptome
profiling was performed by RNA sequencing analysis
in ESCC cells. We identified 316 upregulated genes and
564 downregulated genes after Drp1 overexpression
(Table S4). KEGG pathway analysis revealed that the differentially expressed genes were significantly enriched in
the autophagy and mTOR signaling pathway, cytosolic
DNA-sensing pathway, PI3K-Akt and other signaling
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pathways (Fig. 3A). Autophagy mediates recycling of
cellular components by a series of autophagic vesicles
formed with a membrane bound LC3B-II protein [3, 4,
34]. The autophagy associated genes were significantly
activated after Drp1 overexpression in western blot analyses (Fig. 3B). In KYSE-30 cells, we found that elevated
Drp1 expression significantly increased the LC3B-II protein levels and slightly reduced the levels of SQSTM1/
p62 (Fig. 3C), suggesting mitochondria perturbation by
abnormal Drp1 expression may modulate autophagy.
Moreover, TEM analyses found elevated Drp1 expression increased the number of autophagic vesicles in
KYSE-30 cells (Fig. 3D). In live cell imaging of GFP-LC3B
expressing KYSE-30 cells, elevated Drp1 expression significantly increased the accumulation of GFP-LC3B
puncta (Fig. 3E). In KYSE-30 xenograft tumors, LC3B
staining was significantly increased in Drp1 overexpression compared with tumors in the respective control
group (Fig. 3F). IHC staining showed that the level of
the autophagy marker LC3B was significantly increased
in ESCC patient tumor tissues than peritumor tissues
(Fig. 3G), suggesting autophagy may play a role in ESCC.
Furthermore, treatment with the autophagy inhibitor
chloroquine significantly decreased their colony formation ability and the percentage of EdU positive cells in
KYSE-30 with Drp1 overexpression (Fig. 3H and I), supporting a theme that autophagy is important for tumor
cell proliferation and growth after Drp1 overexpression.
In addition, Mdivi-1 significantly alleviated Drp1-mediated autophagy as shown by reversing the expression of
LC3B-II and SQSTM1/p62, reducing accumulation of
GFP-LC3B puncta and the formation of autophagic vesicles (Fig. 3C-E).
cGAS‑STING signaling pathway is involved in Drp1
overexpression‑mediated autophagy

We and other laboratories previously showed that Drp1
overexpression markedly induces cytosolic mtDNA
stress, which subsequently activates the cGAS-STING or
TLR9 pathway [2, 12]. Recently, the cGAS-STING signaling pathway was found to promote autophagy [35, 36].
Hence, we investigated whether cGAS-STING signaling

(See figure on next page.)
Fig. 2 Drp1 inhibitor or knockdown exhibits an anticancer effect on ESCC in vitro and in vivo. (A and B) Cell proliferation was evaluated
by EdU incorporation assay in ESCC cells with Drp1 knockdown or treatment with 50 μM Mdivi-1 for 12 h as indicated. Scale bar: 200 μm. (C and
D) Colony-forming potential were detected in ESCC cells with Drp1 knockdown or treatment with 50 μM Mdivi-1 for 12 h as indicated. Scale bar:
10 mm. (E and F) Cell viability of ESCC cells with Drp1 knockdown or treatment with 50 μM Mdivi-1 for 12 h as indicated were evaluated using the
MTS cell proliferation assay. (G, H and I, J) Tumor growth curves of subcutaneous xenograft tumor model developed from ESCC cells with Drp1
deficiency (n = 6) or treatment with Mdivi-1 (n = 6). Tumor size including tumor length (L) and width (W) was measured using vernier calipers
every week from second week after transplantation. The tumor volumes were calculated according to the formula (L × W2)/2 and presented
as mean ± SEM. Tumors from sacrificed mice were dissected fifth week after transplantation and were also shown in lower panel. (K and L)
Representative immunohistochemical (IHC) staining images of Ki67 in xenograft tumors developed from KYSE-70 cells with Drp1 deficiency or
treatment with Mdivi-1. Scale bar: 100 μm. The data shown are the mean ± SEM from three independent experiments. *, P < 0.05; **, P < 0.01; ***,
P < 0.001. shDrp1, shRNA expression vector against Drp1; shCtrl, control shRNA
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Fig. 2 (See legend on previous page.)
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Fig. 3 Drp1 overexpression regulates autophagy in ESCC cells. (A) RNA sequencing was performed on ESCC cells as indicated to screen
differentially expressed mRNAs. Signaling pathway were plotted according to enriched gene ratio. (B) Heat map analysis of RNA sequencing
for autophagy associated gene expression in ESCC cells as indicated. (C) Western blot analyses were performed in ESCC cells as indicated with
antibodies specific for the proteins shown. (D) Representative transmission electron microscopy images of double-membrane autophagosomes in
ESCC cells as indicated. Scale bar: 0.5 μm. (E) Representative images of fluorescent LC3B puncta (green) in ESCC cells as indicated. Scale bar: 10 μm.
(F) Representative immunohistochemical (IHC) staining images of LC3B in xenograft tumors developed from KYSE-30 cells as indicated. Scale bar:
100 μm. (F) Colony-forming potential were detected in KYSE-30 cells as indicated. Scale bar: 10 mm. (G) Representative immunohistochemical
(IHC) staining images of LC3B in paired ESCC tissues (n = 61). Scale bar: 100 μm. (H and I) Cell proliferation was evaluated by colony formation EdU
incorporation assay in KYSE-30 cells as indicated. Scale bar: 200 μm. The data shown are the mean ± SEM from three separate experiments. Drp1,
expression vector encoding Drp1; EV, empty vector. P value from t tests. *, P < 0.05; **, P < 0.01; ***, P < 0.001

pathway is involved in Drp1 overexpression-mediated
autophagy. Interestingly, we found TMEM173, which
encoding STING, is downregulated expression after Drp1
overexpression (Fig. 4A). Western blot shown an increase
in the phosphorylation of STING and TBK1 after Drp1
overexpression (Fig. 4B), indicating that the cGASSTING pathway is activated. Further, the total amount
of the STING protein is decreased, suggesting that
STING might undergo autophagy mediated degradation
(Fig. 4B). Upon chloroquine treatment to inhibit the formation of autolysosomes, the amount of STING protein
was restored roughly to the same level with the control
cells (Fig. 4B), supporting that STING was degradation
by autophagy after the alternated expression of Drp1.

Consistently, Mdivi-1 also inhibited STING pathway activation which induced by Drp1 overexpression (Fig. 4C).
Moreover, knockdown of cGAS, an upstream activator
of STING phosphorylation, decreased LC3B lipidation,
attenuated STING and SQSTM1/p62 degradation, suppressed phosphorylation STING and TBK1 in cells with
Drp1 overexpression (Fig. 4D). Furthermore, knockdown
of STING blocked SQSTM1/p62 degradation, TBK-1
phosphorylation and LC3B conversion in cells with Drp1
overexpression (Fig. 4D). In addition, knockdown of
STING with siRNAs in Drp1 overexpression significantly
alleviated the autophagic vesicles formation (Fig. 4E) and
accumulation of GFP-LC3B puncta (Fig. 4F). Together,
these results indicate that cGAS-STING signaling
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Fig. 4 cGAS-STING signaling pathway is involved in Drp1 overexpression-mediated autophagy. (A) Heat map analysis of gene expression
in ESCC cells as indicated. (B, C and D) Western blot analyses were performed in ESCC cells as indicated with antibodies specific for the proteins
shown. (E) Representative transmission electron microscopy images of double-membrane autophagosomes in ESCC cells as indicated. Scale
bar: 0.5 μm. (F) Representative images of fluorescent LC3B puncta (green) in ESCC cells as indicated. Scale bar: 10 μm. The data shown are the
mean ± SEM from three separate experiments. Drp1, expression vector encoding Drp1; EV, empty vector; NC, negative control; CQ, chloroquine;
siSTING, siRNAs against STING; sicGAS, siRNAs against cGAS. P value from t tests. **, P < 0.01; ***, P < 0.001

pathway is involved in Drp1 overexpression-mediated
autophagy in ESCC.
Drp1 overexpression causes mitochondrial dysfunction
and cytosolic mtDNA stress in ESCC cells

RNA sequencing indicated the activation of cytosolic
DNA-sensing pathway (Fig. 3A). According our previously found, the cGAS-STING pathway activation
by Drp1 overexpression prompted us to test if abnormal Drp1 expression regulates mtDNA release into the
cytosol in ESCC. We fist investigated the mitochondrial
function after Drp1 overexpression in ESCC cells. We
observed that Drp1 overexpression decreased mitochondrial membrane potential detected with the JC-1
fluorescent molecule staining (Fig. 5A). In addition,
Drp1 overexpression significantly reduced ATP production (Fig. 5B) and increased cellular reactive oxygen species (ROS) as detected with DCFH-DA staining
in flow cytometry analyses (Fig. 5C). In contrast,
Mdivi-1 treatment markedly retarded mitochondrial
outer membrane permeabilization and ATP depletion,

suppressed ROS production in cells with Drp1 overexpression (Fig. 5A-C). These results indicate abnormal
expression Drp1 may disrupt mitochondrial homeostasis and result in mitochondrial dysfunction.
Moreover, Drp1 overexpression disorganized the
mitochondrial nucleoid architecture and the amount
of picogreen DNA staining areas without overlapping with the MitoTracker-red staining was increased
(Fig. 5D). To analyze the cytosolic mtDNA concentration, the amount of mtDNA in the cytosol fraction
lacking mitochondria was quantified using droplet
digital PCR. Drp1 overexpression markedly increased
mtDNA content as indicated by the increase in mitochondrial ND1 gene DNA in the cytosol than control
cells (Fig. 5E). After DNase I protein was delivered into
the cells, the amount of cytosolic mtDNA was significantly decreased using picogreen staining or droplet
digital PCR analyses, while heat inactivated DNase I
did not affect cytosolic mtDNA content (Fig. 5D and
E). Mdivi-1 treatment also prevented Drp1 overexpression-induced cytosolic mtDNA release (Fig. 5D and F).
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Fig. 5 Drp1 overexpression causes mitochondrial dysfunction and cytosolic mtDNA stress in ESCC cells. (A) Mitochondrial membrane
potential was analyzed by JC-1 staining in ESCC cells as indicated. Scale bars: 100 μm. (B) ATP concentration was measured in ESCC cells as
indicated. (C) ROS production was measured with flow cytometry in ESCC cells as indicated. (D) Confocal microscopy images of indicated ESCC
cells stained with Picogreen (green, DNA) and MitoTracker (red, mitochondria). Scale bar: 20 μm.(E and F) Cytosolic mtDNA content was measured
using droplet digital PCR in ESCC cells as indicated. The data shown are the mean ± SEM from three separate experiments. Drp1, expression vector
encoding Drp1; EV, empty vector; NC, negative control; HI DNase I, heat inactivated DNase I. P value from t tests. *, P < 0.05; **, P < 0.01; ***, P < 0.001

Drp1 overexpression‑induced cytosolic mtDNA stress
is dependent on mPTP

It has been reported that mitochondrial permeability
transition pore (mPTP), BAX/BAK macropores, voltagedependent anion channel 1 (VDAC1) oligomerization,
and/or the formation of globular mitochondria are involved
in mediating mtDNA release under different cell stress [26,
27, 37, 38]. BAX/BAK macropores is appeared in mitochondrial outer membrane after BAK and BAX oligomerization during apoptosis and allows mtDNA to be exposed
to cytoplasm [38]. However, in this study, we found that
Drp1 overexpression inhibited the apoptosis of ESCC cells,
as indicated by downregulation of BAX/Bcl-2 ratio and
cleaved caspase-3 (Fig. 6A). In addition, we observed that
Drp1 overexpression significantly inhibited CCCP-induced
apoptosis of ESCC cells (Fig. 6B). Instead, our results
observed loss of membrane potential (Fig. 5A) and upregulation of ROS (Fig. 5C), which indicated opening of the
mitochondrial permeability transition pore (mPTP) [39].
Previous research had reported that Mdivi-1 directly inhibited mitochondrial outer membrane permeabilization [40],

which was demonstrated by our results (Fig. 5A). Additionally, downregulated expression of Ppid using siRNA
(encoding the mPTP component PPID) or pharmacological inactivation of the mPTP using cyclosporin A (CsA)
prevented Drp1 overexpression-mediated mtDNA release
into the cytoplasm (Fig. 6C and D). VDAC1 is another
component that may participate in cytosolic release of
mtDNA under oxidative stress [37]. Agreement with
our speculated, Drp1 overexpression-mediated cytosolic
mtDNA accumulation is also significantly inhibited after
treatment with VDAC1 oligomerization inhibitor VBIT-4
or siRNA of VDAC1 (Fig. 6C and D). Together, these data
indicated that Drp1 overexpression-induced cytosolic
mtDNA stress is dependent on opening the mPTP and
VDAC1 oligomerization.
Cytosolic mtDNA stress mediates the cGAS‑STING signaling
activation, autophagy induction, and cell proliferation
of ESCC

Consistent with a role of cytosolic mtDNA in the activation of the cGAS-STING pathway, we found DNase I
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Fig. 6 Drp1 overexpression-induced cytosolic mtDNA stress is dependent on mPTP. (A) Western blot analyses were performed in ESCC cells
as indicated with antibodies specific for the proteins shown.(B) Flow cytometry analysis of apoptosis by Annexin V and PI staining in ESCC cells as
indicated. The cells were treated with CCCP (150 mM) for 4 h before apoptosis analysis. (C) Confocal microscopy images of indicated ESCC cells
stained with Picogreen (green, DNA) and MitoTracker (red, mitochondria). Scale bar: 20 μm. (D) Cytosolic mtDNA content was measured using
droplet digital PCR in ESCC cells as indicated. The data shown are the mean ± SEM from three separate experiments. Drp1, expression vector
encoding Drp1; EV, empty vector. siPpid, siRNAs against Ppid; siVDAC1, siRNAs against VDAC1; CsA, cyclosporin A; VBIT, VDAC1 oligomerization
inhibitor VBIT-4. P value from t tests. ***, P < 0.001
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Fig. 7 Cytosolic mtDNA stress mediates the cGAS-STING signaling activation, autophagy induction, and cell proliferation of ESCC. (A)
Western blot analyses were performed in ESCC cells as indicated with antibodies specific for the proteins shown.(B) Representative transmission
electron microscopy images of double-membrane autophagosomes in ESCC cells as indicated. Scale bar: 0.5 μm. (C) Representative images
of fluorescent LC3B puncta (green) in ESCC cells as indicated. Scale bar: 10 μm. (D) Colony-forming potential were detected in KYSE-30 cells as
indicated. Scale bar: 10 mm. (E) Cell proliferation was evaluated by EdU incorporation assay in KYSE-30 cells as indicated. Scale bar: 200 μm. The data
shown are the mean ± SEM from three separate experiments. Drp1, expression vector encoding Drp1; EV, empty vector; NC, negative control; HI
DNase I, heat inactivated DNase I. P value from t tests. *, P < 0.05; **, P < 0.01; ***, P < 0.001

treatment but not the heat inactivated DNase I treatment
attenuated STING phosphorylation after Drp1 overexpression in ESCC cells (Fig. 7A). Moreover, DNase I treatment also blocked LC3B lipidation and the formation of
autophagic vesicles (Fig. 7A and B), suggesting cytosolic
mtDNA plays an important role in activating the cGASSTING signaling pathway and autophagy induction. Furthermore, we found treatment with active DNase I but
not heat inactivated DNase I significantly decreased Drp1
overexpression-mediated accumulation of GFP-LC3B
puncta (Fig. 7C). Additionally, the colony formation
ability and EdU incorporation of ESCC cells with Drp1
overexpression are markedly ameliorated after DNase I
treatment (Fig. 7D and E). These results suggested that
cytosolic mtDNA plays a direct role in cGAS-STING
signaling activation, autophagy induction and proliferation of ESCC cells.
Blocking cGAS‑STING pathway inhibits mtDNA stress
induced ESCC progression.

To test the effect of autophagy mediated by cGASSTING pathway on Drp1 overexpression-induced ESCC

progression, we analyzed cells survival in ESCC cells
treated with cGAS or STING siRNAs. We observed that
Drp1 overexpression-induced EdU incorporation and
proliferative potential were significantly attenuated in
cGAS or STING knockdown cells as compared to control
groups (Fig. 8A and B). Further, we evaluated the cellular effect of STING inhibitor H-151 in Drp1 overexpression-induced ESCC cells survival. Unexpectedly, H-151
slightly increased EdU incorporation and the colony
formation ability in Drp1 overexpression cells (Fig. 8A
and B). In xenograft experiments, H-151 treatment
slightly increased tumor weight, tumor growth rate and
the percentages of K
 i67+ cells in tumor samples (Fig. 8C
and D). In contrast, chloroquine treatment significantly
decreased the promotional effect of H-151 on xenograft
tumor growth and cell proliferation in Drp1 overexpression or TFAM depletion (Fig. 8C and D).
In IHC analyses of xenograft tumors, elevated LC3B
staining was observed after treatment with H-151 than
tumors with Drp1 overexpression, while treatment with
the autolysosome formation inhibitor chloroquine further increased the LC3B accumulation (Fig. 8E). In
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Fig. 8 Blocking cGAS-STING pathway inhibits mtDNA stress induced ESCC progression. (A) Cell proliferation was evaluated by EdU
incorporation assay in KYSE-30 cells treatment with indication. Scale bar: 200 μm. (B) Colony-forming potential were detected in KYSE-30 cells
treatment with indication. Scale bar: 10 mm. (C and D) Tumor growth curves and weight of subcutaneous xenograft tumor model developed from
ESCC cells treatment with indication (n = 5). (E) Representative IHC staining images of Ki67 and LC3B in xenograft tumors developed from KYSE-30
cells treatment with indication. Scale bar: 100 μm. The data shown are the mean ± SEM from three separate experiments. Drp1, expression vector
encoding Drp1; EV, empty vector; NC, negative control; siSTING, siRNAs against STING; sicGAS, siRNAs against cGAS; CQ, chloroquine. P value from t
tests. *, P < 0.05; **, P < 0.01; ***, P < 0.001

Drp1 overexpression cells, H-151 treatment significantly
reduced TBK1 phosphorylation and suppressed IFN-β
expression (Fig. S6A and B), which is consistent with a
role of STING in the phosphorylation of TBK-1 and the
type I interferon gene expression. However, inhibition

of STING by H-151 did not block STING pathwaymediated autophagy, as indicated by further STING and
SQSTM1/p62 degradation (Fig. S6A), as well as the accumulation of autophagic vesicles in TEM assays and GFPLC3B speckle formation analyses (Fig. S6C and D). These
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results suggest that upon activation by mtDNA, STING
plays two distinct roles in promoting autophagy and type
I interferon gene expression, and that STING inhibition
with H-151 is not sufficient to block the autophagy function of STING hence may further increase tumor growth.

Discussion
Accumulating evidence indicates that mitochondrial
dynamics homeostasis is involved in tumor progression
[3, 4]. However, the role of Drp1 in ESCC progression
has not been systematically elucidated. Here, we demonstrated for the first time that a high expression of Drp1
is correlated with poor overall survival of ESCC patients.
Drp1 overexpression significantly induces mitochondrial
dysfunction and cytosolic mtDNA stress, which subsequently activates the cGAS-STING pathway and triggers
autophagy, consequently promotes ESCC cancer growth
(Fig. 9).
Previous studies had shown that mitochondria played a
central and multi-functional role in tumor progression by
modulating mitochondrial mass, dynamics and biogenesis [3, 4]. Consistent with previous findings, we found
that upregulated Drp1 (the critical GTPase for dynamic)
significantly induced mitochondrial dysfunction in ESCC
cells, which is commonly indicated by decreased ATP
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generation and mitochondrial membrane potential, and
increased ROS production. Previous studies had shown
that Drp1 was implicated in tumor progression [3, 4, 34].
Here, our data demonstrated that Drp1 overexpression
promotes survival of ESCC in vitro and in tumor xenograft models, suggesting a critical role of mitochondrial
dynamic homeostasis in ESCC tumor progression.
Mitochondrial dynamics and biogenesis play important roles in nucleoid homeostasis and cristae reformation [1, 8]. Our previous study demonstrated that
increased mitochondrial fission by Drp1 overexpression
may disrupt nucleoid structure and induce cytosolic
mtDNA stress in HCC cells [12]. Consistent with previous reports, we found that the architecture of mitochondrial nucleoids was significantly disorganized and
cytosolic mtDNA content was markedly increased in
Drp1 overexpression ESCC cells. In addition, depletion
of cytosolic mtDNA after DNase I treatment significantly
decreased ESCC cell growth, EdU incorporation, and
xenograft tumor growth, suggesting that mtDNA release
to the cytosol is important for Drp1-mediated cancer cell
growth. The molecular mechanism underlying mitochondrial DNA release into the cytosol is largely unknown.
Mitochondrial permeability transition pore (mPTP),
BAX/BAK macropores, VDAC1 oligomerization, and/

Fig. 9 Schematic depicting the effect of mitochondrial fission-induced mtDNA stress promotes ESCC progression through cGAS-STING pathway
mediated autophagy
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or the formation of globular mitochondria are involved
in mediating mtDNA release under different cell stress
[26, 27, 37, 38]. Our results found that Drp1 may regulate
mtDNA release through opening the mPTP and VDAC1
oligomerization in ESCC cells. Certainly, further studies
should be performed to reveal the underling molecular
mechanisms by which mitochondrial dysfunction mediates the cytosolic mtDNA tress.
Previous study demonstrated that cytosolic mtDNA is
involved in STING signaling-mediated autophagy and
antiviral innate immune response [35, 36]. Our results
indicated that Drp1 overexpression-induced cytosolic
mtDNA stress dramatically upregulates the phosphorylation of TBK1 and STING, and stimulates the formation
of autophagic vesicles and protein turnover. Conversely,
mtDNA depletion significantly abrogated autophagosomes formation and GFP-LC3B fluorescence puncta
accumulation in ESCC cells with Drp1 overexpression. We further found that autophagy inhibitors markedly alleviated Drp1 overexpression-induced survival of
ESCC cells. It has been demonstrated that activation of
the cGAS-STING pathway plays a dichotomous role in
tumor development [22, 24]. Some research has demonstrated that activation of STING signaling also promoted
autophagy [35, 36]. However, whether the autophagy
mediated by STING pathway contributes to tumor progression remain unexplored. In this study, we found that
STING mediated autophagy plays a role in Drp1 overexpression-induced ESCC cells survival. Blocking cGASSTING pathway significantly abrogated autophagy and
ESCC survival induced by Drp1 overexpression. Surprisingly, H-151, a potent and selective covalent antagonist of
STING, failed to suppress Drp1 overexpression-induced
ESCC survival. Conversely, H-151 slightly increased
the ESCC cell growth. We found that H-151 only inhibited STING-mediated immune responses by inhibiting TBK1 phosphorylation and IFN-β expression but
not autophagy. Furthermore, we found that combination chloroquine with H-151 remarkably repressed subcutaneous tumor growth capacity of ESCC cells with
Drp1 overexpression. Collectively, these findings indicate STING-mediated autophagy pathway promotes
ESCC cells survival under mtDNA stress conditions.
Our results raise concerns about the usage of the STING
inhibitors as drugs for ESCC patients. Instead, targeted
suppression of STING-mediated autophagy and simultaneous induction of STING-mediated immune response
serve as better therapeutic strategy for cancer patients.

pathway and induction of autophagy in ESCC cells
(Fig. 9). Our results suggest an important contribution of
the STING pathway to cytosolic mtDNA stress-induced
autophagy, and targeted suppression of STING-mediated
autophagy as a therapeutic strategy for ESCC.

Conclusions
In present study, we observed a cytosolic mtDNA stress
after Drp1 overexpression-induced mitochondrial dysfunction, and subsequent activation of the cGAS-STING
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